Vitrectomy may prevent the occurrence of diabetic macular oedema.
OBJECTIVE
This study aimed to demonstrate that vitrectomy may prevent the occurrence of diabetic macular oedema (DMO).


METHODS
Three patients with diabetes type 1 underwent vitrectomy in one eye to treat complications of proliferative diabetic retinopathy.


RESULTS
During follow-up, all patients suffered unilateral macular oedema in the non-vitrectomized eye as a result of general metabolic changes. In two of these patients, the DMO resolved with management of the underlying medical condition.


CONCLUSIONS
These case reports suggest the vitreous may play a role in the occurrence of DMO associated with general risk factors. Further studies are needed to increase understanding of the mechanisms involved in the development and progression of DMO.
Navarro
Audrey
A
Department of Ophthalmology, Hôpital de la Timone, Marseille, France. audrey.navarro1@gmail.com
Pournaras
Jean-Antoine C
JA
Hoffart
Louis
L
Massin
Pascale
P
Ridings
Bernard
B
Conrath
John
J
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D005260:Female; D006801:Humans; D017075:Laser Coagulation; D008269:Macular Edema / Q000517:prevention & control*; D008297:Male; D012163:Retinal Detachment / Q000601:surgery; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy; D014823:Vitreous Hemorrhage / Q000601:surgery; D055815:Young Adult